Targeting CCR5 with miltefosine as a therapeutic strategy for thrombocytopenia.

iScience · 2025 · PMC12032913 · PMID 40292315

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

TAL1 expression also exhibited a decreasing trend with maraviroc treatment ( Figures 9 and S9 ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.